Finally, THRB is one of the thyroid hormone receptors [142], and defects in its gene are known to confer generalized thyroid hormone resistance, thus opening up new perspectives for the putative use of thyroid hormone therapy to treat NRAS-mutant melanomas [136]. The gene discussed is NRAS; the disease is melanoma.